{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:18:49Z","timestamp":1770977929869,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12957-015-0608-4","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T07:34:38Z","timestamp":1433489678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China"],"prefix":"10.1186","volume":"13","author":[{"given":"Rui","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Qiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-You","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"key":"608_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"608_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/13651820701883148","volume":"10","author":"D Hariharan","year":"2008","unstructured":"Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford). 2008;10:58\u201362.","journal-title":"HPB (Oxford)"},{"key":"608_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","volume":"144","author":"D Yadav","year":"2013","unstructured":"Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1252\u201361.","journal-title":"Gastroenterology"},{"key":"608_CR4","doi-asserted-by":"publisher","first-page":"v55","DOI":"10.1093\/annonc\/mdq165","volume":"21","author":"S Cascinu","year":"2010","unstructured":"Cascinu S, Falconi M, Valentini V, Jelic S. Pancreatic cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v55\u20138.","journal-title":"Ann Oncol"},{"key":"608_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ijsu.2013.10.005","volume":"11","author":"M Distler","year":"2013","unstructured":"Distler M, Pilarsky E, Kersting S, Grutzmann R. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas\u2014a retrospective tumor marker prognostic study. Int J Surg. 2013;11:1067\u201372.","journal-title":"Int J Surg"},{"key":"608_CR6","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","volume":"24","author":"CR Ferrone","year":"2006","unstructured":"Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006;24:2897\u2013902.","journal-title":"J Clin Oncol"},{"key":"608_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1245\/s10434-009-0415-7","volume":"16","author":"M Waraya","year":"2009","unstructured":"Waraya M, Yamashita K, Katagiri H, Ishii K, Takahashi Y, Furuta K, et al. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Ann Surg Oncol. 2009;16:1231\u201340.","journal-title":"Ann Surg Oncol"},{"key":"608_CR8","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1097\/MPA.0b013e31824c11f4","volume":"41","author":"F Tavano","year":"2012","unstructured":"Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, et al. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas. 2012;41:1280\u20134.","journal-title":"Pancreas"},{"key":"608_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jamasurg.2013.2690","volume":"149","author":"BE Kadera","year":"2014","unstructured":"Kadera BE, Sunjaya DB, Isacoff WH, Li L, Hines OJ, Tomlinson JS, et al. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival. JAMA Surg. 2014;149:145\u201353.","journal-title":"JAMA Surg"},{"key":"608_CR10","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/cncr.26553","volume":"118","author":"SC Mayo","year":"2012","unstructured":"Mayo SC, Nathan H, Cameron JL, Olino K, Edil BH, Herman JM, et al. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012;118:2674\u201381.","journal-title":"Cancer"},{"key":"608_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archsurg.2011.2281","volume":"147","author":"MH Katz","year":"2012","unstructured":"Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ. Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. Arch Surg. 2012;147:513\u20139.","journal-title":"Arch Surg"},{"key":"608_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1477-2574.2011.00379.x","volume":"13","author":"TS Kent","year":"2011","unstructured":"Kent TS, Sachs TE, Sanchez N, Vollmer Jr CM, Callery MP. Conditional survival in pancreatic cancer: better than expected. HPB (Oxford). 2011;13:876\u201380.","journal-title":"HPB (Oxford)"},{"key":"608_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/1471-2407-12-460","volume":"12","author":"XQ Yu","year":"2012","unstructured":"Yu XQ, O\u2019Connell DL, Baade PD, O\u2019Connell DL, Baade PD. Conditional survival of cancer patients: an Australian perspective. BMC Cancer. 2012;12:460.","journal-title":"BMC Cancer"},{"key":"608_CR14","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1200\/JCO.2009.25.9697","volume":"28","author":"ML Janssen-Heijnen","year":"2010","unstructured":"Janssen-Heijnen ML, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol. 2010;28:2520\u20138.","journal-title":"J Clin Oncol"},{"key":"608_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.canep.2013.03.019","volume":"37","author":"L Shack","year":"2013","unstructured":"Shack L, Bryant H, Lockwood G, Ellison LF. Conditional relative survival: a different perspective to measuring cancer outcomes. Cancer Epidemiol. 2013;37:446\u20138.","journal-title":"Cancer Epidemiol"},{"key":"608_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(12)70285-1","volume":"13","author":"LC Harshman","year":"2012","unstructured":"Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, et al. Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol. 2012;13:927\u201335.","journal-title":"Lancet Oncol"},{"key":"608_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1634\/theoncologist.2009-0211","volume":"15","author":"RM Merrill","year":"2010","unstructured":"Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist. 2010;15:873\u201382.","journal-title":"Oncologist"},{"key":"608_CR18","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1001\/archinternmed.2011.539","volume":"171","author":"Y Cao","year":"2011","unstructured":"Cao Y, Kenfield S, Song Y, Rosner B, Qiu W, Sesso HD, et al. Cigarette smoking cessation and total and cause-specific mortality: a 22-year follow-up study among US male physicians. Arch Intern Med. 2011;171:1956\u20139.","journal-title":"Arch Intern Med"},{"key":"608_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/archinternmed.2010.536","volume":"171","author":"SM Gapstur","year":"2011","unstructured":"Gapstur SM, Jacobs EJ, Deka A, McCullough ML, Patel AV, Thun MJ. Association of alcohol intake with pancreatic cancer mortality in never smokers. Arch Intern Med. 2011;171:444\u201351.","journal-title":"Arch Intern Med"},{"key":"608_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267\u201377.","journal-title":"JAMA"},{"key":"608_CR21","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2007.15.8469","volume":"26","author":"JM Herman","year":"2008","unstructured":"Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008;26:3503\u201310.","journal-title":"J Clin Oncol"},{"key":"608_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1572-0241.2006.00402.x","volume":"101","author":"P Malfertheiner","year":"2006","unstructured":"Malfertheiner P, Schutte K. Smoking\u2014a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol. 2006;101:160\u20132.","journal-title":"Am J Gastroenterol"},{"key":"608_CR23","doi-asserted-by":"crossref","unstructured":"Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, et al. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Oncogene. 2014. doi:10.1038\/onc.2014.154.","DOI":"10.1038\/onc.2014.154"},{"key":"608_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473\u201381.","journal-title":"JAMA"},{"key":"608_CR25","doi-asserted-by":"publisher","first-page":"e1000267","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7:e1000267.","journal-title":"PLoS Med"},{"key":"608_CR26","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1056\/NEJM200406243502617","volume":"350","author":"CH Crane","year":"2004","unstructured":"Crane CH, Ben-Josef E, Small Jr W. Chemotherapy for pancreatic cancer. N Engl J Med. 2004;350:2713\u20135.","journal-title":"N Engl J Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-015-0608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-015-0608-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-015-0608-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-015-0608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:17:20Z","timestamp":1630592240000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-015-0608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1186\/s12957-015-0608-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]},"assertion":[{"value":"5 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"196"}}